Form 4 for IONS IONIS PHARMACEUTICALS INC
Accepted 2022-09-12 00:00:00 ET · period of report 2022-09-08 · accession 0000874015-22-000157 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-09-12 | 2022-09-08 | IONS | Swayze Eric | EVP Research | S - Sale | $44.55 | -460 | 19.9K | -2% | -$20.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-09-08 | S | D | 460 | $44.55 | 19,892 | D | — | — | (F1) Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on June 20, 2019. |